wire - news in brief

Research by Aziz Debain (Frailty & Resilience in Ageing Research Unit, VUB & Geriatrics Department, UZ Brussels) sheds new light on the impact of medication on the autonomic nervous system in older adults. The study, conducted with over 400 participants over a two-year period, shows that certain medications nearly triple the risk of frailty in older individuals.

A team of scientists led by researchers from the Vrije Universiteit Brussel (VUB) and the Flemish Institute for Biotechnology (VIB) has developed a new technology to precisely predict and monitor cancer patients' responses to immunotherapy. Immunotherapy is a type of cancer treatment that stimulates a patient's immune system to attack tumors.

Brussels, December 9, 2024 - Therapeutic mRNAs offer great potential as a versatile and precise tool against cancer and various other diseases.

With the help of a science-based smartphone app, psychotherapists and psychologists can now enhance their patients' treatment with interventions and assessments in everyday life.

The Belgian-led consortium consisting of groups from The Queen Astrid Military Hospital (QAMH), KU Leuven and the public health institute Sciensano recently made the cover of Nature Microbiology.

Crohn's disease, affecting approximately 2 million people around the world, manifests with intestinal inflammation and abdominal pain.

The World Health Organization reveals a sombre reality: cancer ranks as the world's second-leading cause of death.

KU Leuven and the Danish BioInnovation Institute (BII) will jointly look for new therapeutic drugs for the gynecological disorder endometriosis over the next three years.

Professor Steven Ballet, head of the Organic Chemistry research group at the Vrije Universiteit Brussel, has received the international Evotec Award for Excellence in Molecular Design from the French Société de Chimie Thérapeutique.

Inaugurating a new initiative to foster AI-driven precision medicine via data federation, standardisation, and interoperability.

The Hematology-Immunology research group at VUB and the Hematology department UZ Brussel have received three awards for their research into better treatment of blood cancer.

"The goal is to improve communication between young cancer patients (between 10 and 18 years old), their parents and the medical staff, and thereby also optimise care," says Anne van Driessche, third

The teams of VUB professors Bart Neyns, Sandra Tuyaerts and Karine Breckpot will join research groups from UCL, Bordet Institute and ULB in their search for factors that explain why current immunotherapies fail in all patients.

Professors Michel De Vos and Ellen Anckaert work at UZ Brussel and are affiliated with VUB.

Flemish are more positive about vaccine than Walloons; half of non-vaccinated people do not want to be vaccinated The Vrije Universiteit Brussel and VUB spin-off iCense conducted a survey among Belgians to find out people's reasons for choosing to be vaccinated against Covid-19 or not.

Extension to proven TriMix adjuvant technology intended to boost dendritic cell activation eTheRNA immunotherapies NV ('eTheRNA', Niel, Belgium ), a clinical-stage company developing mRNA-based immun

Icovid is being rolled out across Europe and is on the OECD shortlist for AI initiatives against current and future pandemics The Belgian initiative icovid, which supports radiologists in the assessm

The first Generet Award, which was launched this year, has gone to Professor Miikka Vikkula (de Duve Institute - UCLouvain) for his research seeking a genetic explanation for vascular anomalies.